Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

New approaches can improve cancer care delivery

Physicians can use medical records to track the quality of cancer care and determine whether their patients are receiving the right treatments at the right time. Yet the patient is the only one who ultimately can evaluate the quality of his or her experience while receiving treatment.

15 Dec 2011

More than half of older patients with anemia do not need transfusions after hip surgery

More than half of the older, anemic patients in a New England Journal of Medicine study did not need blood transfusions as they recovered from hip surgery, according to new research co-authored by University of Maryland School of Medicine scientists.

15 Dec 2011

AtheroNova establishes clear development plan for AHRO-001 after positive FDA feedback

AtheroNova Inc., a biotech company focused on the research and development of compounds to regress atherosclerotic plaque has established a clear development plan, including Phase I and Phase II protocol outlines, based on the recently finalized minutes of its pre-IND meeting with the U.S. Food and Drug Administration (FDA) for its AHRO-001, a compound for the treatment of atherosclerosis.

15 Dec 2011

HDE and DEP exposure can lead to development of asthma

A study conducted by researchers at Boston University School of Medicine (BUSM) has found that diesel exhaust particulates (DEP) and house dust extract (HDE) causes pulmonary inflammation that aggravates asthma.

15 Dec 2011

Isis announces addition of three new drug development candidates

Isis Pharmaceuticals, Inc. announced today that it has added three new drugs to its development pipeline, ISIS-APOARx, ISIS-DGAT2Rx and ISIS-FVIIRx.

15 Dec 2011

Liver transplantations for NASH-Cirrhosis increase dramatically

Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity and diabetes.

15 Dec 2011

Researchers discover how statins promote breakdown of plaque in arteries

In a new study, NYU Langone Medical Center researchers have discovered how cholesterol-lowering drugs called statins promote the breakdown of plaque in the arteries. The study was published online by the journal PLoS One on December 6, 2011.

14 Dec 2011

Researchers uncover important source of inflammation for CKD

UC Irvine researchers have uncovered an important source of inflammation seen in people with chronic kidney disease, which is increasingly common due to the epidemic of obesity-related diabetes and hypertension.

14 Dec 2011

JDRF initiates enrollment in metformin clinical study for type 1 diabetes

JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes (T1D) in the REMOVAL study, to test whether metformin-a drug commonly used to treat type 2 diabetes-could help prevent or reduce the risk of cardiovascular complications in people with T1D.

14 Dec 2011

Bronx churches, Montefiore partner to fight against hypertension

Montefiore Medical Center is sponsoring screenings and educational workshops at churches in the Bronx in order to help reduce the risk of cardiovascular disease in congregants who are identified with hypertension. Congregants learn about hypertension, medication management, weight control, healthy cooking habits and perform yoga exercises to reduce stress.

14 Dec 2011

Statins linked with reduced risk of death among hospitalized flu patients

The two main ways to prevent and control influenza today are annual immunization and antiviral drugs. A team of investigators has found that statins, cholesterol-lowering drugs, may offer an additional treatment to complement these approaches and reduce mortality among patients hospitalized with influenza.

14 Dec 2011

Sound sleep despite technology overload: Study

Researchers at the University of Sydney have found there has been no significant change over almost 20 years in the average amount of sleep that Australians are getting. There have been concerns that an average Australian might be losing out on sleep due to the technology overload from computers and mobile phones.

12 Dec 2011

Menarini, Moberg Derma partner to distribute Emtrix in Italy

Moberg Derma AB has entered into a distribution agreement with Menarini Group for Emtrix - for discolored and damaged nails caused by nail fungus (onychomycosis) or nail psoriasis.

9 Dec 2011

Arsenic in rice worrisome

Studies have shown that rice takes up more arsenic from soil than other crops. Now a new study shows that higher arsenic levels are ingested by women who eat as little as half a cup of cooked rice in a day. Currently, there are no limits on the amount of allowable arsenic in rice in the United States. But the Environmental Protection Agency has set arsenic limits in water of 10 parts per billion.

7 Dec 2011

Future of drug discovery and development to be highlighted at 2011 BPS Winter Meeting

The future of drug discovery and development at the bench and in the boardroom will be highlighted at a major international pharmacology conference in London, Tuesday 13 to Thursday 15 December.

7 Dec 2011

Hormone-blocking therapy for prostate cancer does not raise risk of heart attacks

Hormone-blocking therapy for prostate cancer doesn't raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women's Cancer Center.

7 Dec 2011

MSD establishes Asia Research & Development headquarters in Beijing

Merck & Co., Inc., known as MSD outside the United States and Canada, today announced the establishment of an Asia Research & Development (R&D) headquarters for innovative drug discovery and development located in Beijing, China.

6 Dec 2011

Spectrum seeks FDA IND approval for SPI-014 to treat hyperphosphatemia

Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).

5 Dec 2011

Low vitamin D levels associated with higher degrees of insulin resistance

A recent study of obese and non-obese children found that low vitamin D levels are significantly more prevalent in obese children and are associated with risk factors for type 2 diabetes. This study was accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

5 Dec 2011

NASA-developed technology for treatment of hardened arteries in the heart

NASA has signed a patent license agreement that will allow a California company use of NASA-developed technology that could be used to treat hardened arteries in the heart.

3 Dec 2011

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

New approaches can improve cancer care delivery

More than half of older patients with anemia do not need transfusions after hip surgery

AtheroNova establishes clear development plan for AHRO-001 after positive FDA feedback

HDE and DEP exposure can lead to development of asthma

Isis announces addition of three new drug development candidates

Liver transplantations for NASH-Cirrhosis increase dramatically

Researchers discover how statins promote breakdown of plaque in arteries

Researchers uncover important source of inflammation for CKD

JDRF initiates enrollment in metformin clinical study for type 1 diabetes

Bronx churches, Montefiore partner to fight against hypertension

Statins linked with reduced risk of death among hospitalized flu patients

Sound sleep despite technology overload: Study

Menarini, Moberg Derma partner to distribute Emtrix in Italy

Arsenic in rice worrisome

Future of drug discovery and development to be highlighted at 2011 BPS Winter Meeting

Hormone-blocking therapy for prostate cancer does not raise risk of heart attacks

MSD establishes Asia Research & Development headquarters in Beijing

Spectrum seeks FDA IND approval for SPI-014 to treat hyperphosphatemia

Low vitamin D levels associated with higher degrees of insulin resistance

NASA-developed technology for treatment of hardened arteries in the heart

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in